Sodium Fluoride Injection
NDC Package 62072-500-30

11-digit billing NDC: 62072050030

Package Information

Sodium Fluoride (sodium fluoride f-18) injection is sodium Fluoride F 18 Injection is a positron emitting radiopharmaceutical, containing no-carrier-added, radioactive fluoride F18 that is used for diagnostic purposes in conjunction with PET imaging. This formulation utilizes a injection delivery system. Marketed by Kreitchman Pet Center, this product is identified by NDC 62072-500 and is authorized under FDA application ANDA203936.

Identification & Billing

NDC Package Code
62072-500-30
Package Description
30 mL in 1 VIAL, MULTI-DOSE
Product Code
11-Digit Billing Format
62072050030

Clinical Specifications

Proprietary Name
Sodium Fluoride F 18
Non-Proprietary Name
Sodium Fluoride F-18
Substance Name
Sodium Fluoride F-18
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Usage Information
Sodium Fluoride F 18 Injection is a positron emitting radiopharmaceutical, containing no-carrier-added, radioactive fluoride F18 that is used for diagnostic purposes in conjunction with PET imaging. It is administered by intravenous injection. The active ingredient, sodium fluoride F18, has the molecular formula Na[18F] with a molecular weight of 40.99, and has the following chemical structure:Na+18F-Sodium Fluoride F 18 Injection is provided as a ready-to-use, isotonic, sterile, pyrogen-free, preservative-free, clear and colorless solution. Each mL of the solution contains between 370 MBq to 7,400 MBq (10 mCi to 200 mCi) sodium fluoride F18, at the EOS reference time, in 0.9% aqueous sodium chloride. The pH of the solution is between 4.5 and 8. The solution is presented in 30 mL multiple- dose glass vials with variable total volume and total radioactivity in each vial.

Regulatory & Marketing

Labeler Name
Kreitchman Pet Center
Product Type
Human Prescription Drug
FDA Application #
ANDA203936
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-23-2016
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62072-500-30 identifies a specific commercial package of 30 ml in 1 vial, multi-dose of Sodium Fluoride F 18, a human prescription drug labeled by Kreitchman Pet Center. This injection is formulated for intravenous use and contains sodium fluoride f-18 as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kreitchman Pet Center on May 23, 2016. The current certification is valid through December 31, 2027.

How is this Kreitchman Pet Center product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62072050030. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62072-500-30
11-Digit CMS (5-4-2)
62072-0500-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.